NASDAQ:PTGX

Protagonist Therapeutics Inc Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$26.09

+0.550 (+2.15%)

At Close: May 03, 2024

Currently predicting for Mon, 6 May 2024

Trading levels for PTGX

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	26.95	3.28 %
		R2	26.64	2.09 %
		R1	26.44	1.35 %
Current price:			26.09
	Support	S1	25.82	-1.03 %
		S2	25.63	-1.77 %
		S3	25.32	-2.96 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	28.98	11.08 %
		R2	28.35	8.66 %
		R1	26.11	0.0767 %
Current price			26.09
	Support	S1	26.01	-0.307%
		S2	25.76	-1.26%
		S3	25.56	-2.03%

PTGX Predictions History

3 years ago
JS predicted that PTGX for 2020-07-13 is going $15.55 (2.37%)

3 years ago
JingWang predicted that PTGX for 2020-07-13 is going

Rank:

About Protagonist Therapeutics Inc

Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with polycythemia vera and hereditary hemochromatosis, as well as for the treatment of other blood disorder... PTGX Profile

Golden Star

Ticker	Date	Change	Price
CVBF	May 01	2.75%	$16.75
FTSL	May 01	0.282%	$46.03
EQC	Apr 30	0.694%	$18.72
HRB	Apr 30	0.635%	$47.23
BSCQ	Apr 30	0.576%	$19.09
BSJP	Apr 29	0.306%	$22.91
LYG	Apr 29	1.56%	$2.56
ORA	Apr 29	4.68%	$64.48
DHT	Apr 24	3.10%	$11.28
LPLA	Apr 19	3.12%	$262.59

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In